{
  "paper_id": "26f55674badfa21611298e1271eaa2cafdf0ce22",
  "metadata": {
    "title": "Therapeutic Management of COVID-19 Patients: A systematic review Corresponding Author",
    "coda_data_split": "train",
    "coda_paper_id": 8903,
    "coda_has_expert_labels": false,
    "subset": "biorxiv_medrxiv"
  },
  "abstract": [
    {
      "original_text": "Background: SARS-CoV-2 is the cause of the COVID-19 that has been declared a global pandemic by the WHO in 2020. The COVID-19 treatment guidelines vary in each country, and yet there is no approved therapeutic for COVID-19. were included. The search terms included combinations of: COVID, SARS-COV-2, glucocorticoids, convalescent plasma, antiviral, antibacterial. There were no restrictions on the type of study design eligible for inclusion.",
      "sentences": [
        [
          {
            "segment_text": "Background : SARS-CoV-2 is the cause of the COVID-19 that has been declared a global pandemic by the WHO in 2020 .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "The COVID-19 treatment guidelines vary in each country ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "and yet there is no approved therapeutic for COVID-19 .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "were included .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "The search terms included combinations of : COVID ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "SARS-COV-2 , glucocorticoids , convalescent plasma , antiviral , antibacterial .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "There were no restrictions on the type of study design eligible for inclusion .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "As of March 26, 2020, of the initial manuscripts identified (n\u003d449) articles. Forty-one studies were included, of which clinical trials (n\u003d3), (case reports n\u003d7), case series (n\u003d10), retrospective (n\u003d11) and prospective (n\u003d10) observational studies. Thirtysix studies were conducted in China (88%).",
      "sentences": [
        [
          {
            "segment_text": "As of March 26 , 2020 ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "of the initial manuscripts identified ( n \u003d 449 ) articles .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Forty-one studies were included , of which clinical trials ( n \u003d 3 ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "( case reports n \u003d 7 ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "case series ( n \u003d 10 ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "retrospective ( n \u003d 11 ) and prospective ( n \u003d 10 ) observational studies .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Thirtysix studies were conducted in China ( 88 % ) .",
            "crowd_label": "finding"
          }
        ]
      ]
    },
    {
      "original_text": "The most common mentioned and reported medicine in this systematic review was corticosteroids (n\u003d25), followed by Lopinavir (n\u003d21) and oseltamivir (n\u003d16).",
      "sentences": [
        [
          {
            "segment_text": "The most common mentioned and reported medicine in this systematic review was corticosteroids ( n \u003d 25 ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "followed by Lopinavir ( n \u003d 21 ) and oseltamivir ( n \u003d 16 ) .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "3",
    "sentence_num": "9",
    "segment_num": "16",
    "token_num": "190"
  }
}